132 related articles for article (PubMed ID: 6687413)
21. Hypocalcemia associated with metastatic bone disease. A retrospective study.
Raskin P; McClain CJ; Medsger TA
Arch Intern Med; 1973 Oct; 132(4):539-43. PubMed ID: 4742409
[No Abstract] [Full Text] [Related]
22. Severe hypophosphatemic osteomalacia in hormone-refractory prostate cancer metastatic to the skeleton: natural history and pitfalls in management.
Pelger RC; Lycklama A Nijeholt GA; Papapoulos SE; Hamdy NA
Bone; 2005 Jan; 36(1):1-5. PubMed ID: 15663996
[TBL] [Abstract][Full Text] [Related]
23. Metastatic prostate cancer presenting as tumour-induced osteomalacia.
Layman AAK; Joshi S; Shah S
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31315844
[TBL] [Abstract][Full Text] [Related]
24. Distinction between focally accelerated bone formation and osteomalacia in carcinoma of prostate metastasised to bone.
Taube T; Beneton MN; Williams JL; McCloskey EV; Kanis JA
Br J Urol; 1993 Jul; 72(1):98-103. PubMed ID: 8149187
[TBL] [Abstract][Full Text] [Related]
25. Tumor-induced osteomalacia: the importance of measuring serum phosphorus levels.
Halperin F; Anderson RJ; Mulder JE
Nat Clin Pract Endocrinol Metab; 2007 Oct; 3(10):721-5. PubMed ID: 17893691
[TBL] [Abstract][Full Text] [Related]
26. Tumor-induced osteomalacia: lessons learned.
Lewiecki EM; Urig EJ; Williams RC
Arthritis Rheum; 2008 Mar; 58(3):773-7. PubMed ID: 18311810
[TBL] [Abstract][Full Text] [Related]
27. Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse.
Marie PJ; Travers R; Glorieux FH
Endocrinology; 1982 Sep; 111(3):904-11. PubMed ID: 6896684
[TBL] [Abstract][Full Text] [Related]
28. Noninvasive testing in the diagnosis of osteomalacia.
Bingham CT; Fitzpatrick LA
Am J Med; 1993 Nov; 95(5):519-23. PubMed ID: 7646591
[TBL] [Abstract][Full Text] [Related]
29. [Bone metastasis with osteomalacia in cancer of the prostate. 2 cases].
Delbarre F; Ghozlan R; Amor B
Nouv Presse Med; 1975 Apr; 4(17):1277-8. PubMed ID: 168553
[No Abstract] [Full Text] [Related]
30. [Vitamin-sensitive osteomalacia in condensing bone metastases of prostatic origin. Apropos of 2 cases].
Charhon S; Rouillat M; Bouvier M; Meunier PJ; Lejeune E
Rev Rhum Mal Osteoartic; 1981 Jun; 48(6):469-76. PubMed ID: 7256162
[TBL] [Abstract][Full Text] [Related]
31. Hypophosphatemic osteomalacia: association with prostatic carcinoma.
Lyles KW; Berry WR; Haussler M; Harrelson JM; Drezner MK
Ann Intern Med; 1980 Aug; 93(2):275-8. PubMed ID: 7406380
[TBL] [Abstract][Full Text] [Related]
32. Hypocalcemia with osteoblastic metastases in patient with prostate carcinoma. A cause of secondary hyperparathyroidism.
Smallridge RC; Wray HL; Schaaf M
Am J Med; 1981 Jul; 71(1):184-8. PubMed ID: 7246580
[TBL] [Abstract][Full Text] [Related]
33. Short-term effects of vitamin D3 and 1,25-dihydroxyvitamin D3 on osteomalacia in uremic rats fed a low calcium-low-phosphorus diet.
Weisbrode SE
Am J Pathol; 1981 Jul; 104(1):35-40. PubMed ID: 6266257
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer-induced oncogenic hypophosphatemic osteomalacia.
Nakahama H; Nakanishi T; Uno H; Takaoka T; Taji N; Uyama O; Kitada O; Sugita M; Miyauchi A; Sugishita T
Urol Int; 1995; 55(1):38-40. PubMed ID: 7571183
[TBL] [Abstract][Full Text] [Related]
35. [Comparative evaluation of the effectiveness of vitamin D3 preparations (1-alpha-hydroxy- and 1-alpha,25-dihydroxycholecalciferol in various forms of osteoporosis and osteomalacia].
Zarubina NA; Rozhinskaia LIa; Bukhman AI; Dorokhova II; Konnova EV
Probl Endokrinol (Mosk); 1989; 35(3):15-9. PubMed ID: 2762260
[TBL] [Abstract][Full Text] [Related]
36. Presentation of osteomalacia in Kohistani women.
Sahibzada AS; Khan MS; Javed M
J Ayub Med Coll Abbottabad; 2004; 16(3):63-5. PubMed ID: 15631376
[TBL] [Abstract][Full Text] [Related]
37. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
[TBL] [Abstract][Full Text] [Related]
38. Secondary hyperparathyroidism in osteomalacia.
Thalassinos NC; Wicht S; Joplin GF
Br Med J; 1970 Jan; 1(5688):76-9. PubMed ID: 5411449
[TBL] [Abstract][Full Text] [Related]
39. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
[TBL] [Abstract][Full Text] [Related]
40. Tumor-induced osteomalacia: clinical and basic studies.
Shane E; Parisien M; Henderson JE; Dempster DW; Feldman F; Hardy MA; Tohme JF; Karaplis AC; Clemens TL
J Bone Miner Res; 1997 Sep; 12(9):1502-11. PubMed ID: 9286768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
